• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期治疗的苯丙酮尿症成年患者的精神障碍

Psychiatric disorders in adult patients with early-treated phenylketonuria.

作者信息

Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H

机构信息

Department of Pediatric Neurology, University of Heidelberg, Germany.

出版信息

Pediatrics. 1997 Mar;99(3):345-50. doi: 10.1542/peds.99.3.345.

DOI:10.1542/peds.99.3.345
PMID:9041285
Abstract

OBJECTIVE

To determine psychiatric disorders in patients with phenylketonuria (PKU) and to test whether biochemical control, intellectual functioning, white matter abnormalities visible on magnetic resonance imaging (MRI), and/or style of parenting influence psychopathology.

DESIGN AND SUBJECTS

This cross-sectional study consisted of 35 PKU patients 17 to 33 years of age (mean: 22.2). From a total of 67 patients, 3 patients were selected because of other causes of possible brain damage. Then 35 patients were randomly drawn with comparison with a control sample (n = 181) from an epidemiologic study.

METHODS

We used a standardized, highly structured, face-to-face interview; intelligence quotient (IQ) test; cranial MRI (n = 26); and monitoring of plasma phenylalanine.

RESULTS

The overall rate of psychiatric disorders was 25.7% in PKU patients and 16.1% in controls. This difference was not statistically significant. The pattern of psychiatric disturbances was different for PKU patients and controls (Fisher's exact test): in PKU patients, externalizing disorders were reduced (PKU: not present, controls: 7.8%), whereas internalizing disorders (PKU: 25.7%, controls: 8.3%) were increased. International Classification of Diseases, version 10, diagnoses were predominantly those of the depressive category and more frequent in women (8 of 18 females and 1 of 17 males). A correlation between IQ and both biochemical control up to 12 years of age and school education of parents was confirmed. No correlation was found between the severity or pattern of psychiatric disturbances and school education of parents, biochemical control, IQ, or the extension of MRI-visible, white matter abnormalities. It was found that a restrictive controlling style of parenting is a risk factor for the development of psychiatric symptoms.

CONCLUSIONS

Our results support a psychological perspective for the development of psychiatric symptoms in PKU. Thus, optimizing medical treatment necessary to prevent brain damage should be accompanied by psychiatric monitoring and psychological support for the families.

摘要

目的

确定苯丙酮尿症(PKU)患者的精神障碍,并测试生化控制、智力功能、磁共振成像(MRI)可见的白质异常和/或养育方式是否会影响精神病理学。

设计与研究对象

这项横断面研究包括35名年龄在17至33岁之间(平均:22.2岁)的PKU患者。在总共67名患者中,有3名患者因其他可能导致脑损伤的原因被排除。然后从一项流行病学研究的对照样本(n = 181)中随机抽取35名患者进行比较。

方法

我们采用了标准化的、高度结构化的面对面访谈;智商(IQ)测试;头颅MRI(n = 26);以及血浆苯丙氨酸监测。

结果

PKU患者的精神障碍总体发生率为25.7%,对照组为16.1%。这种差异无统计学意义。PKU患者和对照组的精神障碍模式不同(Fisher精确检验):PKU患者的外化障碍减少(PKU:无,对照组:7.8%),而内化障碍(PKU:25.7%,对照组:8.3%)增加。国际疾病分类第10版诊断主要为抑郁类别,且在女性中更常见(18名女性中有8名,17名男性中有1名)。证实了智商与12岁之前的生化控制以及父母的学校教育之间存在相关性。未发现精神障碍的严重程度或模式与父母的学校教育、生化控制、智商或MRI可见的白质异常范围之间存在相关性。发现限制性的养育控制方式是精神症状发展的一个危险因素。

结论

我们的结果支持从心理学角度看待PKU患者精神症状的发展。因此,在优化预防脑损伤所需的医学治疗的同时,应伴有精神科监测和对家庭的心理支持。

相似文献

1
Psychiatric disorders in adult patients with early-treated phenylketonuria.早期治疗的苯丙酮尿症成年患者的精神障碍
Pediatrics. 1997 Mar;99(3):345-50. doi: 10.1542/peds.99.3.345.
2
Neurocognitive functioning in adults with phenylketonuria: results of a long term study.成人苯丙酮尿症患者的神经认知功能:一项长期研究的结果。
Mol Genet Metab. 2013;110 Suppl:S44-8. doi: 10.1016/j.ymgme.2013.08.013. Epub 2013 Aug 31.
3
Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.与糖尿病患者和健康对照相比,早期接受治疗的苯丙酮尿症青少年的行为和情绪问题。
J Inherit Metab Dis. 2000 Jul;23(5):487-96. doi: 10.1023/a:1005664231017.
4
The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.早期治疗的苯丙酮尿症患者白质异常的结局:一项回顾性纵向长期研究。
Mol Genet Metab. 2015 Nov;116(3):171-7. doi: 10.1016/j.ymgme.2015.08.005. Epub 2015 Aug 10.
5
Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
Eur J Pediatr. 1996 Jul;155 Suppl 1:S59-63. doi: 10.1007/pl00014252.
6
Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria.早期接受苯丙酮尿症治疗患者的精神病理学:德国苯丙酮尿症协作研究结果
Acta Paediatr Suppl. 1994 Dec;407:108-10. doi: 10.1111/j.1651-2227.1994.tb13467.x.
7
Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.非苯丙酮尿症高苯丙氨酸血症未经治疗患者的智力、神经及神经心理转归。德国苯丙酮尿症协作研究
Pediatr Res. 1997 Sep;42(3):378-84. doi: 10.1203/00006450-199709000-00020.
8
[Brain white matter lesions of children with phenylketonuria before and after treatment].苯丙酮尿症患儿治疗前后的脑白质病变
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Feb;8(1):13-6.
9
Intellectual development and academic achievement of children treated early for phenylketonuria.早期接受苯丙酮尿症治疗儿童的智力发育和学业成绩。
Dev Med Child Neurol. 1979 Jun;21(3):311-20. doi: 10.1111/j.1469-8749.1979.tb01623.x.
10
Behaviour and school achievement in patients with early and continuously treated phenylketonuria.早期持续接受治疗的苯丙酮尿症患者的行为与学业成绩
J Inherit Metab Dis. 2000 Sep;23(6):548-62. doi: 10.1023/a:1005669610722.

引用本文的文献

1
Intelligence quotient scores among early-treated phenylketonuria patients: results from a systematic literature review.早期治疗的苯丙酮尿症患者的智商得分:一项系统文献综述的结果
Orphanet J Rare Dis. 2025 Jun 20;20(1):314. doi: 10.1186/s13023-025-03830-0.
2
Amino Acid Profile Alterations in Phenylketonuria: Implications for Clinical Practice.苯丙酮尿症患者氨基酸谱的改变:对临床实践的启示。
Metabolites. 2024 Jul 21;14(7):397. doi: 10.3390/metabo14070397.
3
Relationship satisfaction in adults with phenylketonuria is positively associated with following recommended treatment, having a partner involved in management, and maintaining good health.
患有苯丙酮尿症的成年人的关系满意度与遵循推荐治疗、让伴侣参与管理以及保持良好健康状况呈正相关。
J Community Genet. 2023 Dec;14(6):627-638. doi: 10.1007/s12687-023-00667-7. Epub 2023 Oct 6.
4
Expert Consensus on the Long-Term Effectiveness of Medical Nutrition Therapy and Its Impact on the Outcomes of Adults with Phenylketonuria.医学营养治疗的长期疗效及其对成人苯丙酮尿症患者结局影响的专家共识。
Nutrients. 2023 Sep 11;15(18):3940. doi: 10.3390/nu15183940.
5
Psychopathological Risk Assessment in Children with Hyperphenylalaninemia.高苯丙氨酸血症患儿的精神病理风险评估
Children (Basel). 2022 Oct 31;9(11):1679. doi: 10.3390/children9111679.
6
Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre.成人苯丙酮尿症患者的精神健康诊断:英国大型单中心回顾性系统审计。
Orphanet J Rare Dis. 2021 Dec 20;16(1):520. doi: 10.1186/s13023-021-02138-z.
7
Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.早期治疗苯丙酮尿症患者中苯丙氨酸持续降低与注意力改善相关。
Am J Med Genet A. 2022 Mar;188(3):768-778. doi: 10.1002/ajmg.a.62574. Epub 2021 Nov 26.
8
A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials.一项非干预性观察性研究,旨在识别和验证用于苯丙酮尿症成人患者临床试验的临床结局评估指标。
Mol Genet Metab Rep. 2021 Nov 9;29:100810. doi: 10.1016/j.ymgmr.2021.100810. eCollection 2021 Dec.
9
The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland-The Results of a National Online Survey.COVID-19 大流行对波兰苯丙酮尿症患者健康和治疗相关问题认知的影响——全国在线调查结果。
Int J Environ Res Public Health. 2021 Jun 13;18(12):6399. doi: 10.3390/ijerph18126399.
10
Psychological well-being of early and continuously treated phenylketonuria patients.早期持续接受治疗的苯丙酮尿症患者的心理健康状况
JIMD Rep. 2021 Feb 21;59(1):69-80. doi: 10.1002/jmd2.12202. eCollection 2021 May.